nach oben

Erschienen in:

03.08.2020 | Zervixkarzinom | Zertifizierte Fortbildung

Zervixkarzinom, Blasenkarzinom und andere Tumorentitäten

Hyperthermie in der Therapie von malignen Beckentumoren

verfasst von: Dr. med. Emsad Puric, Emanuel Stutz, Prof. Dr. med. Lars Lindner, Andreas Meister, Thomas Kern, Niloy R. Datta, Susanne J. Rogers, Oliver Riesterer

Erschienen in: InFo Hämatologie + Onkologie | Ausgabe 7-8/2020

Einloggen, um Zugang zu erhalten

Auszug

Die gezielte Überwärmung von Gewebe ist ein alter Ansatz in der Therapie maligner Erkrankungen. Lesen Sie in dieser Übersicht, worin Effekte und Wirkmechanismen moderner Hyperthermieverfahren bestehen und wie sich diese in der Behandlung von pelvinen Tumoren (im Zusammenspiel mit Chemo- und/oder Radiotherapie) klinisch nutzen lassen. …

Breasted JH. The Edwin Smith Surgical Papyrus, Volume 1: Hieroglyphic Transliteration, Translation, and Commentary. In: Institute O (Hrsg.). Oriental Institute Publications, 1930

Hippocrates. On the Articulations. The Genuine Works of Hippocrates. Clin Orthop Relat Res. 2002;(400):19-25

Hornback NB. Historical aspects of hyperthermia in cancer therapy. Radiol Clin North Am. 1989;27(3):481-8

Overgaard J. The heat is (still) on--the past and future of hyperthermic radiation oncology. Radiother Oncol. 2013;109(2):185-7

Datta NR et al. Integrating loco-regional hyperthermia into the current oncology practice: A SWOT and TOWS analysis. Front. Oncol. 2020; https://doi.org/10.3389/fonc.2020.00819

Datta NR et al. Local Hyperthermia Combined With Radiotherapy and-/or Chemotherapy: Recent Advances and Promises for the Future. Cancer Treat Rev. 2015;41(9):742-53

van der Zee J et al. Point-counterpoint: What Is the Optimal Trial Design to Test Hyperthermia for Carcinoma of the Cervix? Point: Addition of Hyperthermia or Cisplatin to Radiotherapy for Patients With Cervical Cancer; Two Promising Combinations--No Definite Conclusions. Int J Hyperthermia. 2002;18(1):19-24

Franckena M et al. Long-term Improvement in Treatment Outcome After Radiotherapy and Hyperthermia in Locoregionally Advanced Cervix Cancer: An Update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys. 2008;70(4):1176-82

Lutgens LC et al. Radiation Therapy Combined With Hyperthermia Versus Cisplatin for Locally Advanced Cervical Cancer: Results of the Randomized RADCHOC Trial. Radiother Oncol. 2016;120(3):378-82

10.

Repasky EA et al. Temperature Matters! And Why It Should Matter to Tumor Immunologists. Cancer Immunol Res. 2013;1(4):210-6

11.

Frey B et al. Old and New Facts About Hyperthermia-Induced Modulations of the Immune System. Int J Hyperthermia. 2012;28(6):528-42

12.

Datta NR et al. Hyperthermia and Radiotherapy With or Without Chemotherapy in Locally Advanced Cervical Cancer: A Systematic Review With Conventional and Network Meta-Analyses. Int J Hyperthermia. 2016;32(7):809-21

13.

van der Zee J et al. Comparison of Radiotherapy Alone With Radiotherapy Plus Hyperthermia in Locally Advanced Pelvic Tumours: A Prospective, Randomised, Multicentre Trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355(9210):1119-25

14.

Lutgens L et al. Combined Use of Hyperthermia and Radiation Therapy for Treating Locally Advanced Cervix Carcinoma. Cochrane Database Syst Rev. 2010;(3):CD006377

15.

Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials. J Clin Oncol. 2008;26(35):5802-12

16.

Westermann AM et al. First Results of Triple-Modality Treatment Combining Radiotherapy, Chemotherapy, and Hyperthermia for the Treatment of Patients With Stage IIB, III, and IVA Cervical Carcinoma. Cancer. 2005;104(4):763-70

17.

Flameling B et al. An international multicenter phase III study of chemoradiotherapy versus chemoradiotherapy plus hyperthermia for locally advanced cervical cancer. J Clin Oncol. 2017;34(15_suppl):e17023

18.

Harima Y et al. A Multicentre Randomised Clinical Trial of Chemoradiotherapy Plus Hyperthermia Versus Chemoradiotherapy Alone in Patients With Locally Advanced Cervical Cancer. Int J Hyperthermia. 2016;32(7):801-8

19.

Wang Y et al. Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020;107(3):499-511

20.

Hutton B et al. The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. PLoS One. 2014;9(3):e92508

21.

Datta NR et al. Efficacy and Safety Evaluation of the Various Therapeutic Options in Locally Advanced Cervix Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. Int J Radiat Oncol Biol Phys. 2019;103(2):411-37

22.

van der Zee J et al. Cervical cancer: radiotherapy and hyperthermia. Int J Hyperthermia. 2006;22(3):229-34

23.

Issels RD et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;11(6):561-70

24.

Casali PG et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv51-iv67

25.

Issels RD et al. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. JAMA Oncol. 2018;4(4):483-92

26.

Angele MK et al. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg. 2014;260(5):749-54

27.

Schuebbe GE et al. Effect of regional hyperthermia (RHT) in combination with neo-adjuvant chemotherapy for treatment of locally advanced high-risk soft-tissue sarcoma is not dependent on etoposide. Abstract ID 0414. Oncol Res Treat. 2016;39(suppl 1):VII-191

28.

Liem EI et al. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations. Int J Hyperthermia. 2016;32(4):363-73

29.

Arends TJ et al. Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer. J Urol. 2014;192(3):708-13

30.

James ND et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 2012;366(16):1477-88

31.

Wittlinger M et al. Quadrimodal Treatment of High-Risk T1 and T2 Bladder Cancer: Transurethral Tumor Resection Followed by Concurrent Radiochemotherapy and Regional Deep Hyperthermia. Radiother Oncol. 2009;93(2):358-63

32.

Datta NR et al. A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy. Front Oncol. 2019;9:889

33.

Sauer R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl. 2004;351(17):1731-40

34.

Glimelius B. Recurrent Rectal Cancer. The Pre-Irradiated Primary Tumour: Can More Radiotherapy Be Given? Colorectal Dis. 2003;5(5):501-3

35.

Hahnloser D et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237(4):502-8

36.

Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg. 2001;18(5):355-62

37.

Rodel C et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum. 2000;43(3):312-9

38.

Schlag PM, Rau B. Surgical and multimodal therapy of recurrent rectum carcinoma. Langenbecks Arch Chir Suppl Kongressbd. 1997;114:717-9

39.

Hildebrandt B et al. Treatment of locally recurrent rectal cancer with special focus on regional pelvic hyperthermia. Onkologie. 2004;27(5):506-11

40.

Hildebrandt B et al. Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study. Int J Hyperthermia. 2004;20(4):359-69

41.

De Haas-Kock DF et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev. 2009;(3):CD006269

42.

Juffermans JH et al. Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. Cancer. 2003;98(8):1759-66

43.

Schaffer M et al. Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer--preliminary results. Onkologie. 2003;26(2):120-4

44.

Datta NR et al. Hyperthermia with photon radiotherapy is thermoradiobiologically analogous to neutrons for tumors without enhanced normal tissue toxicity. Int J Hyperthermia. 2019;36(1):1073-8

45.

Tran S et al. Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas. Br J Radiol. 2020;93(1107):20180883

46.

Chi MS et al. External Beam Radiation and Hyperthermia Versus External Beam Radiation Alone in Treating Patients With Painful Bony Metastases: A Phase 3 Prospective, Randomized, Controlled Trial. Int J Radiat Oncol Biol Phys. 2018;100(1):78-87

47.

Wu JS et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55(3):594-605

Titel: Zervixkarzinom, Blasenkarzinom und andere Tumorentitäten
Hyperthermie in der Therapie von malignen Beckentumoren
verfasst von: Dr. med. Emsad Puric
Emanuel Stutz
Prof. Dr. med. Lars Lindner
Andreas Meister
Thomas Kern
Niloy R. Datta
Susanne J. Rogers
Oliver Riesterer
Publikationsdatum: 03.08.2020
Verlag: Springer Medizin
Schlagwörter: Zervixkarzinom
Strahlentherapie
Zervixkarzinom
Onkologie
Erschienen in: InFo Hämatologie + Onkologie / Ausgabe 7-8/2020
Print ISSN: 2662-1754
Elektronische ISSN: 2662-1762
DOI: https://doi.org/10.1007/s15004-020-8149-6

Dieses Jahr Konkurrenz mit 14 Bewerbern

Pflege
Neues aus der Industrie

Venetoclax plus Azacitidin verlängert Gesamtüberleben signifikant

Akute myeloische Leukämie
Neues aus der Industrie

Harnblasenkarzinoms: "Daten zum Blasenerhalt sind exorbitant gut und der neue Benchmark"

Harnblasenkarzinom
Kommentierte Studie

Digitale Transparenz soll das Arzt-Patienten-Verhältnis stärken

Onkologie
Praxis konkret

Biomarker beim malignen Melanom

Melanom
Medizin aktuell

Wirksamkeitsvorteil mit Obinutuzumab

Lymphome
Neues aus der Industrie